Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Antengene, Biocity, Catalyst, Hutchmed, Innovent, Junshi, Leo Pharma, Merco & Co., Nxera, Sanofi, Vifor.